A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...

A new microchip invented by Scripps Research scientists can reveal how a person’s antibodies interact with viruses—using just a drop of blood. The technology offers researchers faster, clearer ...

A team at Scripps Research has created a microchip that can rapidly reveal how a person's antibodies respond to viruses using only a drop of blood. This game-changing technology, called mEM, condenses ...

Some antibodies neutralize the virus effectively, while others bind only weakly. Pinpointing exactly which parts of a virus ...

A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just a drop of ...

CRISPR construct to genetically ablate the GABA transporter GAT3 in the mouse visual cortex, with effects on population-level neuronal activity. This work is important, as it sheds light on how GAT3 ...

Several ASX-listed biotechs are advancing cell therapies to capture a share of a global market projected to reach US$48 billion by 2034.

An update from SAB Biotherapeutics ( ($SABS) ) is now available. On July 17, 2025, SAB Biotherapeutics, Inc. held its Annual Meeting of ...

The new system, known as microfluidic EM-based polyclonal epitope mapping (mEM), offers researchers faster, clearer insights that could help accelerate vaccine development and antibody discovery.

Global Annual sales AUD$7.3 million up 49% on prior yearJune 2025 Quarter AUD$2.0 million up 55% on prior year Australia Annual sales AUD$5.2 million up 40% on prior yearJune ...

This release has been authorised by the directors of Immuron Limited.